Ethnopsychopharmacology

Ethnopsychopharmacology - Ethnic Drug Vibes

• Studies ethnic variations in drug response & metabolism.
• Key Factors: Genetic (e.g., CYP450 enzymes), environmental, cultural beliefs, diet.
• Impacts: Drug efficacy, side effects, optimal dosage.
  • E.g., Asians may require ↓ doses of some antipsychotics (e.g., risperidone) due to slower metabolism (CYP2D6 variants).
• Considers cultural views on illness & treatment acceptance.

⭐ Certain ethnic groups (e.g., some East Asians) show higher rates of Stevens-Johnson syndrome with carbamazepine due to HLA-B*1502 allele presence. Test before prescribing!

Pharmacokinetics (PK) - Ethnic Drug Routes

• Ethnic variations significantly alter drug ADME (Absorption, Distribution, Metabolism, Excretion).
• Metabolism: Cytochrome P450 (CYP) enzyme polymorphisms are key drivers.
  • CYP2D6: Metabolizes many antidepressants (e.g., TCAs, SSRIs) & antipsychotics (e.g., risperidone).
    • Indian populations show diverse frequencies of poor (PM), intermediate (IM), extensive (EM), and ultra-rapid (UM) metabolizer phenotypes.
    • Alters drug efficacy and risk of adverse drug reactions.
  • CYP2C19: Affects diazepam, clomipramine, citalopram. Higher PM prevalence in some Asian populations, including Indian groups.
  • CYP2C9: Important for warfarin, phenytoin metabolism.
• Absorption: Genetic variations in drug transporters (e.g., P-glycoprotein encoded by ABCB1 gene).
• Distribution: Differences in body composition (fat vs. muscle), plasma protein binding. ⭐ > CYP2D6 polymorphism is a major determinant of response and tolerability to risperidone; Indian populations exhibit considerable allelic diversity, impacting optimal dosing strategies for schizophrenia treatment.

Pharmacodynamics (PD) - Ethnic Drug Targets

• Genetic variations in drug targets (receptors, transporters) cause differing drug effects across ethnicities.
• Examples:
  • SERT (SLC6A4) (5-HTTLPR): Impacts SSRI response (S-allele vs. L-allele).
  • DRD2 (Taq1A): Affects antipsychotic efficacy & Tardive Dyskinesia risk (A1 allele).
  • COMT (Val158Met): Influences dopamine breakdown, affecting drug response.
  • BDNF (Val66Met): May modify antidepressant outcomes.
• Result: Varied efficacy & side effect profiles.

⭐ The DRD2 Taq1A A1 allele, linked to ↓ D2 receptor density, often predicts poorer response to typical antipsychotics.

Genetic Polymorphisms - DNA Drug Codes

• Genetic variations alter drug pharmacokinetics (PK) & pharmacodynamics (PD).
• Cytochrome P450 (CYP) Enzymes:
  • CYP2D6: Metabolizes many antidepressants (TCAs, SSRIs), antipsychotics (risperidone).
    • Phenotypes: Ultrarapid (UM), Extensive (EM), Intermediate (IM), Poor (PM).
    • UMs: ↑ metabolism → therapeutic failure. PMs: ↓ metabolism → toxicity.
  • CYP2C19: Metabolizes diazepam, clomipramine. Higher PM prevalence in Asians.
• HLA Alleles & Hypersensitivity:
  • HLA-B*1502: Strong link to carbamazepine-induced SJS/TEN.
  • HLA-A*3101: Carbamazepine hypersensitivity.
• Impact: Guides drug selection & dosing for personalized therapy.

⭐ HLA-B*1502 testing is crucial before carbamazepine in at-risk populations (e.g., Asian ancestry) to prevent SJS/TEN.

Cultural Factors & Clinical Pearls - Mind Over Meds

• Diet & Herbs: Turmeric (CYP3A4 inducer), grapefruit (inhibitor) alter drug levels. Inquire about traditional remedies (e.g., Ashwagandha) for interactions.
• Beliefs & Stigma: Influence illness perception, help-seeking, and medication adherence. Address with sensitivity.
• Genetic Variations: CYP2D6, CYP2C19 polymorphisms common; may require dose adjustments (↑ or ↓).
• Clinical Pearls: Start low, go slow. Psychoeducation is vital. Culturally sensitive family involvement.

⭐ CYP2D6 polymorphisms, prevalent in Indian populations, significantly impact metabolism of many TCAs, SSRIs, and risperidone, often necessitating dose adjustments.

High‑Yield Points - ⚡ Biggest Takeaways

• Genetic polymorphisms (e.g., CYP2D6, CYP2C19) alter psychotropic metabolism across ethnicities.
• Some Indian populations show slower metabolism of TCAs & SSRIs, needing dose ↓.
• Dietary habits (e.g., turmeric) can cause drug interactions.
• Cultural views affect medication adherence and side effect reporting.
• Therapeutic Drug Monitoring (TDM) is key with suspected ethnic variations.
• ADR profiles may differ; e.g., ↑ risk of antipsychotic-induced metabolic syndrome in some groups.
• Always consider ethnicity for dose individualization.